ABATACEPT

abatacept 125 mg/mL injection, 4 x 1 mL syringes

ABATACEPT (1221G)

abatacept 125 mg/mL injection, 4 x 1 mL syringes
1221G
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: First continuing treatment

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: First continuing treatment - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 4 # of repeats: 5 DPMQ: $947.29 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Orencia